The NCRI Cellular Molecular Pathology Initiative (CMPath) was launched in 2016 to reinvigorate UK academic pathology. The initiative was created in recognition of the importance of pathology in drug development and clinical research and aims to change the way pathologists engage with, conduct and are recognised for their work in clinical trials in the UK.

CMPath is chaired by Professor David Harrison and consists of multiple workstreams that focus on different areas of work, each aiming to be transformative for pathology research in the UK and beyond.